Oral Session 1-12D ALL: Clinical Trials

[OS1-12D-4] Combination of clofarabine, etoposide, and cyclophosphamide in adult RR-ALL; JALSG RR-ALL214

Takeshi Saito¹, Yoshihiro Hatta², Fumihiko Hayakawa³, Kiyotoshi Imai⁴, Yuichi Yahagi¹, Tsutomu Takahashi⁵, Maki Hagihara⁶, Hiroatsu Iida⁷, Koichiro Minauchi⁸, Etsuko Yamazaki⁹, Isamu Sugiura¹⁰, Tohru Murayama¹¹, Toru Sakura¹², Naoki Mori¹³, Yoshiko Atsuta¹⁴, Akiko Saito¹⁵, Akihiro Hirakawa¹⁶, Hitoshi Kiyoi¹⁷, Itaru Matsumura¹⁸, Yasushi Miyazaki¹⁹ (1.Div. of Clinical Oncology/Hematology, The Jikei Univ., Tokyo, 2.Div. of Hematology/Rheumatology, Nihon Univ., Tokyo, 3.Dep. of Pathophysiological Laboratory Sciences, Nagoya Univ., Nagoya, 4.Dep. of Internal Medicine, Miyanomori Hospital, Sapporo, 5.Dep. of Oncology/Hematology, Shimane Univ. Hospital, Izumo, 6.Dep. of Hematology/Clinical Immunology, Yokohama City Univ., Yokohama, 7.National Hospital Organization Nagoya Medical Center, Nagoya, 8.Dep. of Hematology, Sapporo Hokuyu Hospital, Sapporo, 9.Clinical Laboratory Department, Yokohama City Univ., Yokohama, 10.Div. of Hematology/Oncology, Toyohashi Municipal Hospital, Toyohashi, 11.Dep. of Hematology, Hyogo Cancer Center, Akashi, 12.Hematology, Saiseikai Maebashi Hospital, Maebashi, 13.Dep. of Hematology, Tokyo Womens Medical Univ., Tokyo, 14.Japanese Data Cebter for Hematopoietic Cell Transplantation, Nagoya, 15.Clinical Research Center, National Hospital Organization Nagoya Medical Center, 16.Dep. of Biostatics/Bioinformatics, Graduate School of Medicine. Tokyo Univ., Tokyo, 17.Dep. of Hematology/Oncology, Nagoya Univ. Graduate School of Medicine, Nagoya, 18.Dep. of Hematology/Rheumatology, Kindai Univ. Hospital, Faculty of Medicine, Osaka, 19.Dep. of Hematology, Atomic Bomb Institute, Nagasaki Univ., Nagasaki)